
Elvina Almuradova/X
May 16, 2025, 08:41
Elvina Almuradova: Treatment Algorithm For HER+/HER2- Metastatic Breast Cancer
Elvina Almuradova, Associate Professor of Oncology at the European Institute of Oncology (IEO), shared a post on X:
” 1L: AI or Fulv + CDK4/6i
2L:
PI3K and ESR1 wt: Fulv + Everolimus / Abemaciclib
ESR1 mut: Elacestrant
PI3K mut: Fulv + Alpelisib / Capivasertib
3L+: Options incl. chemo, Elacestrant, Olaparib, T-DXd
4L+: SG, DATO-DXd, biomarkers”
More posts featuring Elvina Almuradova
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 16, 2025, 08:41
May 16, 2025, 08:32
May 16, 2025, 08:21
May 16, 2025, 08:12
May 16, 2025, 07:54
May 16, 2025, 07:50
May 16, 2025, 07:27